343 related articles for article (PubMed ID: 24332479)
1. Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
Sun HL; Han B; Zhai HP; Cheng XH; Ma K
Surgeon; 2014 Jun; 12(3):141-7. PubMed ID: 24332479
[TBL] [Abstract][Full Text] [Related]
2. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
3. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
[TBL] [Abstract][Full Text] [Related]
6. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
Shen C; Shi Y; Liang T; Su P
Dig Endosc; 2017 May; 29(3):281-290. PubMed ID: 28112441
[TBL] [Abstract][Full Text] [Related]
7. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
[TBL] [Abstract][Full Text] [Related]
8. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis.
Li X; Tao LP; Wang CH
World J Gastroenterol; 2014 Sep; 20(34):12322-9. PubMed ID: 25232268
[TBL] [Abstract][Full Text] [Related]
10. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis.
Liu L; Li C; Huang Y; Jin H
J Gastrointest Surg; 2019 Oct; 23(10):1991-2001. PubMed ID: 30251071
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis.
Rustagi T; Njei B
Pancreas; 2015 Aug; 44(6):859-67. PubMed ID: 26168316
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis.
Ding X; Chen M; Huang S; Zhang S; Zou X
Gastrointest Endosc; 2012 Dec; 76(6):1152-9. PubMed ID: 23164513
[TBL] [Abstract][Full Text] [Related]
14. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis.
Dai HF; Wang XW; Zhao K
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):11-6. PubMed ID: 19208508
[TBL] [Abstract][Full Text] [Related]
15. Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials.
Shi N; Deng L; Altaf K; Huang W; Xue P; Xia Q
Turk J Gastroenterol; 2015 May; 26(3):236-40. PubMed ID: 26006198
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
Li L; Han Z; Yuan H; Zhang G; Jia Y; He C
J Hepatobiliary Pancreat Sci; 2017 Sep; 24(9):520-529. PubMed ID: 28681997
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis.
Hou YC; Hu Q; Huang J; Fang JY; Xiong H
Sci Rep; 2017 Apr; 7():46650. PubMed ID: 28440297
[TBL] [Abstract][Full Text] [Related]
19. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
20. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
Wan J; Ren Y; Zhu Z; Xia L; Lu N
BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
